Boardroom Alpha
Boardroom Alpha
OTIS · Additional Proxy Materials (DEFA14A) · Filed May 7, 2026

Otis Worldwide Corp — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
May 7, 2026
Ticker
OTIS
Accession
0001140361-26-019556
Boardroom Alpha · Filing insights

Otis Worldwide urges shareholders to vote in the 2026 meeting. It cites an external UBS proxy email about four proposals.

About Otis Worldwide Corp
Market cap
$27.0B
1Y TSR
−22.5%
3Y TSR
−3.9%
Board grade
C
Sector
Industrials
CEO
Judith Fran Marks
Last annual meeting: May 27, 2026 · View full Otis Worldwide Corp profile →

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

 Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No.  )

 
Filed by the Registrant
Filed by a party other than the Registrant

CHECK THE APPROPRIATE BOX:
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
 
Definitive Additional Materials
 
Soliciting Material under §240.14a-12

Otis Worldwide Corporation

(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY):
No fee required
Fee paid previously with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11



Dear Otis Leader,
 
On April 17, 2026, Otis filed proxy materials with the Securities and Exchange Commission in connection with our 2026 Annual Meeting of Shareholders, expected to take place on May 27, 2026.

I am writing to encourage you to vote your shares before the annual meeting. On or about April 22, 2026, Otis colleagues holding votable shares (as defined below1) of Otis stock in an Otis-sponsored UBS account received an external email from the following sender:

From: UBS FINANCIAL SERVICES INC id@proxyvote.com
Subject: OTIS WORLDWIDE CORPORATION Annual Meeting

If you have not done so, please follow the instructions in that email to cast your vote. Our Board and management team have made the following voting recommendations on the four proposals up for vote:

As an Otis shareholder, it is important to exercise your right to vote, helping shape our future in line with our vision to give people freedom to connect and thrive in a taller, faster, smarter world. Our full proxy statement is available at our investor relations website (www.otisinvestors.com). If you have further questions about the proxy voting process, please contact your UBS financial advisor directly or reply to this email.

Thank you for your continued support of Otis.

Sincerely,

Susan Grady
SVP, Corporate Secretary


[1] Only vested shares in the stock of Otis Worldwide Corporation (NYSE: OTIS) are deemed votable. If you hold only unvested OTIS shares or other OTIS stock-related holdings (e.g., stock appreciation rights (SARs)), or if you hold OTIS shares outside of UBS, you may not have received the email from UBS referenced herein.


Important Additional Information Regarding Proxy Solicitation
 
Otis has filed a proxy statement with the Securities and Exchange Commission (“SEC”) in connection with the solicitation of proxies for the Company’s 2026 Annual Meeting of Shareholders (the “Proxy Statement” and such meeting the “2026 Annual Meeting”). Otis, its directors and certain of its executive officers will be participants in the solicitation of proxies from shareholders in respect of the 2026 Annual Meeting. Information regarding the names of Otis directors and executive officers and their respective interests in Otis by security holdings or otherwise is set forth in the Proxy Statement, filed with the SEC on April 17, 2026 and available at www.otisinvestors.com. Please refer to the sections captioned “Stock ownership,” “Compensation of directors” and “Summary compensation table” in the Proxy Statement. To the extent holdings of such participants in Otis securities have changed since the amounts described in the Proxy Statement, such changes have been reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC. Additional information can also be found in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on February 5, 2026 and available at https://www.sec.gov/Archives/edgar/data/1781335/000178133526000011/otis-20251231.htm.

Details concerning the nominees of the Otis Board of Directors for election at the Annual Meeting are included in the Proxy Statement. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND STOCKHOLDERS OF OTIS ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH OR FURNISHED TO THE SEC, INCLUDING OUR DEFINITIVE PROXY STATEMENT AND ANY AMENDMENTS AND SUPPLEMENTS THERETO BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. These documents, including the definitive Proxy Statement (and any amendments or supplements thereto) and other documents filed by Otis with the SEC, are available for no charge at the SEC’s website at http://www.sec.gov and at our investor relations website at www.otisinvestors.com.



From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Otis Worldwide Corp (OTIS)

Reference

Frequently asked questions

When did Otis Worldwide Corp file this DEFA14A?
Otis Worldwide Corp (OTIS) filed this Additional Proxy Materials (DEFA14A) with the SEC on May 7, 2026. The accession number assigned by EDGAR is 0001140361-26-019556.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Otis Worldwide urges shareholders to vote in the 2026 meeting. It cites an external UBS proxy email about four proposals. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Otis Worldwide Corp's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Otis Worldwide Corp has filed under CIK 1781335, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer